(Q27852083)
Statements
1 reference
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study (English)
1 reference
March 2013
0 references
14
0 references
3
0 references
249-56
0 references